Literature DB >> 18386990

Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome.

Erika Roat1, Nicole Prada, Enrico Lugli, Milena Nasi, Roberta Ferraresi, Leonarda Troiano, Chiara Giovenzana, Marcello Pinti, Ornella Biagioni, Mauro Mariotti, Angelo Di Iorio, Ugo Consolo, Fiorella Balli, Andrea Cossarizza.   

Abstract

Down syndrome (DS), the most common chromosomal abnormality in humans, is characterized by precocious immunologic aging that results, among other things, in alterations of B and T lymphocyte subsets and natural killer cells, defective phagocytosis, and chemotaxis of polymorphonuclear leukocytes. We studied 30 children affected by DS, compared them to 29 healthy controls, and evaluated the functionality of the thymus (by measuring the amount of lymphocytes that express the signal-joint T cell receptor rearrangement excision circles [sj-TREC+]), the plasma levels of interleukin (IL)-7 and IL-15, the proliferative T cell response to these cytokines, the expression of the alpha chain of the IL-7 receptor (CD127), the extrathymic differentiation of T lymphocytes, and the presence of natural regulatory T cells (Tregs) in peripheral blood. We found that DS children had a significantly lower number of sj-TREC+ lymphocytes, the levels of which were strongly correlated with age. We found higher plasma levels of IL-7 and IL-15 than in healthy controls, and a higher proliferative T cell response to IL-15. DS children also showed a lower percentage of CD4(+) cells and profound alterations of T cell differentiation, along with increased amount of Tregs and of cells expressing markers of apoptosis. We can thus hypothesize that the precocious thymic involution occurring in DS is mirrored by a high production of IL-7 and IL-15, which is crucial for cell survival and proliferation. The complex alterations present in the periphery are likely the result of a compensatory mechanism: the overproduction of homeostatic cytokines could be a reaction to the impaired intrathymic production of T lymphocytes and/or to the expansion of Treg in the periphery, and could be required to allow the survival of T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18386990     DOI: 10.1089/rej.2007.0648

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  14 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

3.  Newborn screening for SCID in New York State: experience from the first two years.

Authors:  Beth H Vogel; Vincent Bonagura; Geoffrey A Weinberg; Mark Ballow; Jason Isabelle; Lisa DiAntonio; April Parker; Allison Young; Charlotte Cunningham-Rundles; Chin-To Fong; Jocelyn Celestin; Heather Lehman; Arye Rubinstein; Subhadra Siegel; Leonard Weiner; Carlos Saavedra-Matiz; Denise M Kay; Michele Caggana
Journal:  J Clin Immunol       Date:  2014-03-01       Impact factor: 8.317

4.  Down syndrome, autoimmunity and T regulatory cells.

Authors:  F P Pellegrini; M Marinoni; V Frangione; A Tedeschi; V Gandini; F Ciglia; L Mortara; R S Accolla; L Nespoli
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 5.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

6.  Thymopoiesis and regulatory T cells in healthy children and adolescents.

Authors:  Maria Izabel Arismendi; Esper Georges Kallás; Bianca Almeida Natali dos Santos; Magda Maria Sales Carneiro-Sampaio; Cristiane Kayser
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

7.  Identification of a DNA methylation signature in blood cells from persons with Down Syndrome.

Authors:  Maria Giulia Bacalini; Davide Gentilini; Alessio Boattini; Enrico Giampieri; Chiara Pirazzini; Cristina Giuliani; Elisa Fontanesi; Maria Scurti; Daniel Remondini; Miriam Capri; Guido Cocchi; Alessandro Ghezzo; Alberto Del Rio; Donata Luiselli; Giovanni Vitale; Daniela Mari; Gastone Castellani; Mario Fraga; Anna Maria Di Blasio; Stefano Salvioli; Claudio Franceschi; Paolo Garagnani
Journal:  Aging (Albany NY)       Date:  2015-02       Impact factor: 5.682

Review 8.  The importance of the nurse cells and regulatory cells in the control of T lymphocyte responses.

Authors:  María Guadalupe Reyes García; Fernando García Tamayo
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

9.  Differential Expression of Inflammation-Related Genes in Children with Down Syndrome.

Authors:  Cláudia Regina Santos Silva; Joice Matos Biselli-Périco; Bruna Lancia Zampieri; Wilson Araujo Silva; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2016-05-11       Impact factor: 4.711

10.  Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome.

Authors:  Marlon Fraga Mattos; Patrícia Matos Biselli-Chicote; Joice Matos Biselli; Thiago Luís da Silva Assembleia; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2018-08-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.